BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25925777)

  • 1. Demographic, Hematologic, and Clinical Features of Myelodysplastic Syndrome Patients: Results from the First Polish Myelodysplastic Syndrome Registry.
    Mądry K; Machowicz R; Waszczuk-Gajda A; Drozd-Sokołowska J; Hołowiecka BS; Wiater E; Mital A; Obara A; Szmigielska-Kapłon A; Kołkowska-Leśniak A; Sikorska A; Subocz E; Mendrek W; Szczepańska M; Biedroń M; Jachalska A; Wasilewska E; Wojciechowska M; Guzicka-Kazimierczak R; Kopacz A; Katinas K; Kruger W; Dawidowska A; Salamańczuk Z; Zawirska D; Świderska A; Jędrzejczak WW; Dwilewicz-Trojaczek J
    Acta Haematol; 2015; 134(2):125-34. PubMed ID: 25925777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry.
    Waszczuk-Gajda A; Mądry K; Machowicz R; Drozd-Sokołowska J; Stella-Hołowiecka B; Mital A; Obara A; Szmigielska-Kapłon A; Sikorska A; Subocz E; Jędrzejczak WW; Dwilewicz-Trojaczek J
    Adv Clin Exp Med; 2016; 25(4):633-41. PubMed ID: 27629836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological data on myelodysplastic syndrome patients under 50 years in a single center of Romania.
    Gologan R
    Leuk Res; 2010 Nov; 34(11):1442-6. PubMed ID: 20189246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome.
    Gonzalez-Porras JR; Cordoba I; Such E; Nomdedeu B; Vallespi T; Carbonell F; Luño E; Ardanaz M; Ramos F; Pedro C; Gomez V; de Paz R; Sanchez-Barba M; Sanz GF; Del Cañizo AC;
    Cancer; 2011 Dec; 117(24):5529-37. PubMed ID: 21638279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological data from the registry of patients with myelodysplastic syndrome in a single hospital center of Romania.
    Gologan R; Georgescu D; Tatic A; Radulescu I; Vasilache D
    Leuk Res; 2009 Nov; 33(11):1556-61. PubMed ID: 19411107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are myelodysplastic syndromes underdiagnosed in Poland? A report by the Polish Adult Leukaemia Group.
    Drozd-Sokołowska JE; Mądry K; Waszczuk-Gajda A; Żółtak T; Sikorska A; Mital A; Wajs J; Semeńczuk G; Szmigielska-Kapłon A; Szczepańska M; Wasilewska E; Szwedyk P; Hołojda J; Wątek M; Stella-Hołowiecka B; Soroka-Wojtaszko M; Homenda W; Polak M; Guzicka-Kazimierska R; Porowska A; Wiktor-Jędrzejczak W; Dwilewicz-Trojaczek J
    Eur J Haematol; 2017 Feb; 98(2):154-159. PubMed ID: 27699872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of -308A TNFα is associated with anemia and thrombocytopenia in patients with myelodysplastic syndromes.
    Belli CB; Bestach Y; Sieza Y; Gelemur M; Giunta M; Flores MG; Watman N; Bengió R; Larripa I
    Blood Cells Mol Dis; 2011 Dec; 47(4):255-8. PubMed ID: 21983349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long term risk of myelodysplastic syndromes among anemia patients: a population-based study.
    Meytes D; Chodick G; Shalev V; Porath A
    Leuk Res; 2012 Mar; 36(3):327-30. PubMed ID: 22142797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome.
    Chan G; DiVenuti G; Miller K
    Am J Hematol; 2002 Nov; 71(3):166-71. PubMed ID: 12410570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult Primary Myelodysplastic Syndrome: Experience from a Tertiary Care Center in Pakistan.
    Sultan S; Irfan SM
    Asian Pac J Cancer Prev; 2016; 17(3):1535-7. PubMed ID: 27039802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.
    Neukirchen J; Blum S; Kuendgen A; Strupp C; Aivado M; Haas R; Aul C; Gattermann N; Germing U
    Eur J Haematol; 2009 Nov; 83(5):477-82. PubMed ID: 19548919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case-control study.
    Nisse C; Lorthois C; Dorp V; Eloy E; Haguenoer JM; Fenaux P
    Leukemia; 1995 Apr; 9(4):693-9. PubMed ID: 7723405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany.
    Gattermann N; Kündgen A; Kellermann L; Zeffel M; Paessens B; Germing U
    Eur J Haematol; 2013 Dec; 91(6):473-82. PubMed ID: 24102637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of myelodysplastic syndromes: a case-control study.
    Strom SS; Gu Y; Gruschkus SK; Pierce SA; Estey EH
    Leukemia; 2005 Nov; 19(11):1912-8. PubMed ID: 16167059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hematologic response predictor factors in adults with myelodysplastic syndromes (SMD) treated with cyclosporin A (CSA)].
    Zamora-Pérez E; López-Karpovitch X
    Gac Med Mex; 2015; 151(3):345-53. PubMed ID: 26089271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study.
    Vijenthira A; Premkumar D; Callum J; Lin Y; Wells RA; Chodirker L; Lenis M; Mamedov A; Buckstein R
    Leuk Res; 2019 Jan; 76():76-81. PubMed ID: 30580105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No increase in age-specific incidence of myelodysplastic syndromes.
    Germing U; Strupp C; Kündgen A; Bowen D; Aul C; Haas R; Gattermann N
    Haematologica; 2004 Aug; 89(8):905-10. PubMed ID: 15339672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse impact of hyperferritinemia and transfusion dependency on treatment success in myelodysplastic syndrome.
    Cakar MK; Yegin ZA; Baysal NA; Altındal S; Pamukçuoğlu M; Celik B; Yenicesu I
    Transfus Apher Sci; 2013 Jun; 48(3):397-401. PubMed ID: 23619324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes.
    Martín M; de Paz R; Jiménez-Yuste V; Fernández Bello I; García Arias Salgado E; Alvarez MT; Butta NV
    Thromb Haemost; 2013 May; 109(5):909-19. PubMed ID: 23407717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The application of a new prognostic score system for 435 cases of primary myelodysplastic syndrome diagnosed with WHO classification].
    Wang XQ;
    Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):633-7. PubMed ID: 19954053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.